This BCC Research report provides an overview of the current and future states of the RNA Sequencing (RNA Seq) market for the years 2015, 2016 and 2020 in segments such as instruments, tools and reagents, data analysis, and services.
Use this report to:
Analyze various segments of the RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, and RNA-Sequencing services Identify the main factors affecting each segment and forecast their market growth, future trends and product development Evaluate infrastructure for the health and growth of the RNA-Sequencing market as a whole
The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8 million in 2015, a CAGR of 13.0%. The services segment should reach $460.5 million by 2020 from $170.5 million in 2015, a CAGR of 9.1%.
STUDY GOALS AND OBJECTIVES
This BCC Research report, RNA Sequencing: Technologies and Global Markets, provides an overview of the current and future states of the RNA Sequencing (RNA-Seq) market for the years 2015, 2016 and 2020 in the following segments: instruments, tools and reagents, data analysis, and services. Special emphasis is placed on RNA-Seq technology development because RNA-Seq depends on the development of new and improved high throughput sequencing technologies.
This report describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new or potential trends in research and product development. This report also includes information regarding opportunities and obstacles affecting this market and its different sectors.
Each of the four RNA-Seq segments has healthy growth potential. Each of them also face serious and unique challenges. This report has a comprehensive discussion of technologies as well as the competitive landscape in the global market. It is designed to aim companies in their strategic planning efforts for exploiting RNA-Seq industry opportunities.
REASONS FOR DOING THE STUDY
RNA-Seq, introduced around 2010, is a method for transcriptomics. In a few short years, it has become the method of choice for transcriptome studies, rapidly replacing another transcriptomics method; the microarray. Transcriptomics is the study of transcriptome, the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell, using high-throughput methods.
RNA-Seq not only provides benefits to the scientific research community, but also has huge clinical potential in diagnostics and drug discovery. The RNA-Seq industry is an emerging, evolving and important biomedical sector; a comprehensive and critical study about its technologies and markets is needed for better understanding.
SCOPE AND FORMAT
The geographic scope is global. The RNA-Seq market is complex, consisting of a number of different segments. The market segments are: RNA-Seq instruments; RNA-Seq tools and reagents; RNA-Seq data analysis and RNA-Seq services. Each segment is affected differently by technological and regulatory developments. This report identifies the main factors affecting each segment and forecasts market growth, future trends and product development in every major market segment. Market forecasts are given for the years 2015, 2016 and 2020.
The report is organized by presenting the core segment (sequencing instruments) first, followed by its derivative segments (tools and reagents, data analysis, services). The development of sequencing instruments is vital for RNA-Seq development; thus sequencing instruments segment is classified as the core segment. However, it does not suggest that the derivative segments are not important. In fact, the RNA-Seq instruments segment is neither the biggest nor the fastest growing among the four segments. The instruments segment, however, provides the infrastructure for the health and growth of the RNA-Seq market as a whole.
Our reports have been used by over 10K customers, including:
Market Overview The metabolomics market was valued at USD 1,637.43 million in 2018, and is expected to reach USD 3,565.82 million by 2024. It is estimated to register a CAGR of 13.85%, during the forecast period (2019-2024). The high growth rate for this market is primarily due to its high demand in scientific communities...
Global Blockchain in Genomics Market to Grow at a CAGR of 66.42% from 2019-2029 Key Questions Answered in the Report: • What are the major market drivers, challenges, and opportunities in the global blockchain in genomics market? • What are the underlying structures resulting in the emerging trends...
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This report provides you with a landscape description and analysis of discovery and development of small molecules against RNA as a drug target from an industry perspective as of September...
136 pages •
By Global Industry Analysts
• Oct 2019
RNA Analysis/Transcriptomics market worldwide is projected to grow by US$4.8 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%. The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number...
173 pages •
By Global Industry Analysts
• Oct 2019
NGS-based RNA-seq market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 20.7%. Sample Preparation, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
Increased focus on human microbiome therapy development to drive the growth of this market. The global human microbiome market is projected to reach USD 1,731 million in 2027 from 942 million in 2024, at CAGR of 22.5 % during the forecast period. Market growth is largely driven by the increasing focus on the development...
Market Overview The global SNP genotyping market was valued at USD 12.3 billion in 2018, and is estimated to be valued at USD 38.6 billion in 2024, witnessing a CAGR of 21%. The analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants...
Population Genomics-National Initiatives and Implementation Population genomics initiatives launched in several nations have significantly transformed the entire healthcare industry.With the advancements in technology and the allocation of government funding for the implementation of these programs has profoundly reshaped...
253 pages •
By Global Industry Analysts
• Oct 2019
RNA Interference (RNAi) market worldwide is projected to grow by US$39.9 Billion, driven by a compounded growth of 18.5%. Drug Discovery & Development, one of the segments analyzed and sized in this study, displays the potential to grow at over 18.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.